Production (Stage)
E
Fractyl Health, Inc. GUTS
$2.16 -$0.72-25.00% NASDAQ
Recommendation
Prev Close
$2.88
Volume
1,144,809
Avg Vol (90D)
286,582
Market Cap
$141.05M
Dividend & Yield
--
52-Week Range
$0.873 - $6.54
P/E (TTM)
--
EPS (TTM)
-$1.84
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Fractyl Health (GUTS) and Bariendo Explore Collaboration for Weight Management GUTS Stock News
6/4/2025 - GuruFocus
Fractyl Health, Bariendo sign non-binding LOI, to offer Revita nationwide
6/4/2025 - The Fly
Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita Across its Bariatric and Metabolic Endoscopy Centers Nationwide
6/4/2025 - Globe Newswire
68,000 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Purchased by Northstar Financial Companies Inc.
5/28/2025 - Ticker Report
Canaccord Genuity Sticks to Its Buy Rating for Fractyl Health, Inc. (GUTS)
5/20/2025 - TipRanks Financial Blog
Fractyl Health (GUTS) Submits Initial CTA Module for Gene Therapy in Europe GUTS Stock News
5/19/2025 - GuruFocus
Fractyl Health submits first module of its CTA in Europe for RJVA-001
5/19/2025 - The Fly
Fractyl Health Advances Rejuva Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
5/19/2025 - Globe Newswire
Fractyl Health Unveils New Rejuva Smart GLP-1 Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
5/17/2025 - Globe Newswire
Fractyl Health (GUTS) Advances with Promising Study Enrollment
5/14/2025 - GuruFocus
Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript
5/14/2025 - Seeking Alpha: Transcripts
Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript
5/14/2025 - SeekingAlpha
Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates
5/13/2025 - GuruFocus
Fractyl Health Inc Reports Q1 2025 Net Loss of $23.7 Million Amid Increased R&D Investments
5/13/2025 - GuruFocus
Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates
5/13/2025 - Globe Newswire
Fractyl Health (GUTS) to Release Quarterly Earnings on Monday
5/7/2025 - MarketBeat
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on ...
5/6/2025 - GuruFocus
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
5/6/2025 - Globe Newswire
Fractyl Health to Present Compelling Preclinical Data from its Rejuva Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
4/28/2025 - Globe Newswire
Discover Fractyl Health And 2 More Promising Penny Stocks
4/22/2025 - Simply Wall St
Canaccord Begins Coverage of Fractyl Health (GUTS) with Optimistic Outlook GUTS Stock News
4/15/2025 - GuruFocus
Fractyl Health initiated with bullish view at Canaccord, here's why
4/15/2025 - The Fly
Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025
4/2/2025 - Insider Monkey
10 Micro-Cap Stocks Insiders Were Buying In Q1 2025
4/2/2025 - Insider Monkey
Fractyl Health reports early data from REVEAL-1 cohort of REMAIN-1 study
4/1/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$60.00K
EBITDA (TTM)
-$95.83M
EBIT (TTM)
-$96.75M
Net Income (TTM)
-$89.11M
Balance Sheet
Total Assets (Q)
$83.04M
Total Debt (Q)
$61.43M
Total Liabilities (Q)
$76.67M
Book Value Per Share (Q)
$0.1303
Cash Flow
Cash from Operations (TTM)
-$78.89M
Cash from Investing (TTM)
-$1.15M
Cash from Financing (TTM)
$395.00K
Net Change in Cash (TTM)
-$79.65M
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
--
7-Day Total Return
13.68%
30-Day Total Return
80.00%
60-Day Total Return
68.75%
90-Day Total Return
11.34%
Year to Date Total Return
1.41%
1-Year Total Return
-66.77%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 10, 2025 - $0.873
52-week High
Jun 10, 2024 - $6.54
Valuation
Market Cap
$141.05M - Micro Cap
Enterprise Value
$160.37M
Price/Sales (TTM)
2,400.00
Price/Book (Q)
22.10
Dividends and Shares
Shares Outstanding
48.87M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
fractyl.com
Phone Number
781 902 8800
Address
3 Van de Graaff Drive
Burlington, MA 01803
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient... more
NASDAQ 06/10/2025 4:00PM Eastern Quotes delayed